Maxillofacial Prosthodontics for the Pediatric Patient: “An Eye-Opening Experience”

The following case report describes the expanding role of pediatric dentists in treating children with craniofacial pathology. Retinoblastoma is the most common intraocular malignancy in childhood and is approximately the tenth most common pediatric cancer in the United States. Treatment consists of enucleation, or removal of the entire globe followed by placement of orbital implants. Un-restored anopthalmic sockets exhibit growth retardation and can lead to facial disfigurement. Maxillofacial prosthetic (MFP) rehabilitation can be especially challenging in younger, pre-cooperative or behaviorally compromised children and requires the skills and participation of a pediatric dental specialist as part of the MFP team. The following case report involving a 3 yr-old girl with retinoblastoma describes such challenges. The objective of the maxillofacial prosthetic team was to provide custom-built, acrylic, bilateral ocular prostheses in as comfortable and atraumatic manner as possible. The case was a success and underscores the value of a multidisciplinary dental approach for the treatment of children with very special needs.

Retinoblastoma, maxillofacial prosthesis, ocular prosthesis, children

1. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Can-cer Inst 96(5): 357–63, 2004.

2. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term sur-vivors of retinoblastoma: an extended follow-up. J Clin Oncol 23(10): 2272–9, 2005.

3. Melamud A, Palekar R, Singh A. Retinoblastoma. Am Fam Physician 73(6): 1039–44, 2006.

4. Seregard S, Lundell G, Svedberg H, Kivela T. Incidence of retinoblas-toma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology 111(6): 1228–32, 2004.

5. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol 98(7): 1204–10, 1980.

6. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer 95(8): 1767–72, 2002.

7. Orjuela M, Castaneda VP, Ridaura C, Lecona E, Leal C, Abramson DH, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res 6(10): 4010–6, 2000.

8. Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol 15(3): 1183–9, 1997.

9. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 23(16): 3742–51, 2005.

10. Sykes LM, Essop AR, Veres EM. Use of custom-made conformers in the treatment of ocular defects. J Prosthet Dent 82(3): 362–5, 1999.

11. Cerullo L. Plastic artificial eyes: overview and technique. Advances in Ophthalmic, Plastic, & Reconstructive Surgery 8: 25–45, 1990.

12. Christmas NJ, Gordon CD, Murray TG, Tse D, Johnson T, Garonzik S, et al. Intraorbital implants after enucleation and their complications: a 10- year review. Arch Ophthalmol 116(9): 1199–203, 1998.

13. Chuah CT, Chee SP, Fong KS, Por YM, Choo CT, Luu C, et al. Inte-grated hydroxyapatite implant and non-integrated implants in enucle-ated Asian patients. Ann Acad Med Singapore 33(4): 477–83, 2004.

14. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucle-ation: a survey of 5,439 intraorbital implants and a review of the litera-ture. Ophthal Plast Reconstr Surg 11(2):77-86; discussion 87–8, 1995.

15. Custer PL, Kennedy RH, Woog JJ, Kaltreider SA, Meyer DR. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology 110(10): 2054–61, 2003.

16. Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 78(9): 702–6, 1994.

17. Yago K, Furuta M. Orbital development after enucleation without orbital implant in early childhood. Nippon Ganka Gakkai Zasshi 105(6): 374–8, 2001.

18. Christmas NJ, Van Quill K, Murray TG, Gordon CD, Garonzik S, Tse D, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 118(4): 503–6, 2000.

19. Yago K, Furuta M. Orbital growth after unilateral enucleation in infancy without an orbital implant. Jpn J Ophthalmol 45(6): 648–52, 2001.

20. Lubkin V, Sloan S. Enucleation and psychic trauma. Adv Ophthalmic Plast Reconstr Surg 8: 259–62, 1990.

21. Egawa S, Tsukiyama I, Akine Y, Kajiura Y, Ogino T. Suppression of bony growth of the orbit after radiotherapy for retinoblastoma. Radiat Med 5(6): 207–11, 1987.

22. Moss-Salentijn L. Melvin L. Moss and the functional matrix. J Dent Res 76(12): 1814–7, 1997.

23. Chuang SY. The relationship between masticatory function and cranio-facial morphology. Gaoxiong Yi Xue Ke Xue Za Zhi 11(8): 458–69, 1995.

24. Krastinova D, Kelly MB, Mihaylova M. Surgical management of the anophthalmic orbit, part 1: congenital. Plast Reconstr Surg 108(4): 817–26, 2001.

25. Eppley BL, Holley S, Sadove AM. Experimental effects of intraorbital tissue expansion on orbitomaxillary growth in anophthalmos. Ann Plast Surg 31(1): 19-26; discussion 26–7, 1993.

26. Bentley RP, Sgouros S, Natarajan K, Dover MS, Hockley AD. Normal changes in orbital volume during childhood. J Neurosurg 96(4): 742–6, 2002.

27. Gundlach KK, Guthoff RF, Hingst VH, Schittkowski MP, Bier UC. Expansion of the socket and orbit for congenital clinical anophthalmia. Plast Reconstr Surg 116(5): 1214–22, 2005.

28. Furuta M. Measurement of orbital volume by computed tomography: especially on the growth of the orbit. Jpn J Ophthalmol 45(6): 600–6, 2001.